针对性去除HCV E2 N2 N-甘氨酸与小鼠免疫反应的改善有关
Yuan-Qin Min1,2, Yu-Shan Ren3, Wen-Wen Zhang1
1Hubei Province Key Laboratory of Allergy and Immunology, Department of Immunology, Taikang Medical School (School of Basic Medical Sciences), Wuhan University, Wuhan 430071, China.
Biomolecules
|February 27, 2026
概括
在肝炎C病毒E2糖蛋白上有针对性地去除特定的N-甘氨酸可增强免疫反应. 这一策略提高了疫苗的疗效和对抗HCV感染的治疗潜力.
科学领域:
- 病毒学和免疫学 病毒学和免疫学
- 疫苗开发 疫苗开发
背景情况:
- 肝炎C病毒 (HCV) 缺乏经许可的疫苗.
- E2包膜糖蛋白是中和抗体的关键目标.
- 在E2上的N-甘氨酸可以屏蔽表位,可能限制疫苗的有效性.
研究的目的:
- 调查E2上的单位N-甘氨酸删除是否能够保持抗原完整性.
- 在DNA免疫模型中,评估N-glycan编辑是否能改善免疫反应.
- 在感染HCV的小鼠中评估改性E2的治疗潜力.
主要方法:
- 在保存的N-糖化位点产生了分泌的E2ectodomain (sE2384-661) 的五个N-to-D突变.
- 在小鼠的DNA免疫模型中评估的突变物,具有受控的CpG含量和输送.
- 评估了抗体标位,病毒抑制,细胞免疫反应 (IFN-γ,B粒酶,穿孔素),体外/体内瘤模型,以及感染HCV小鼠的治疗性疫苗接种.
主要成果:
- N2突变 (sE2-N2) 保持表达和分泌,显示较高的抗E2标位和增强抑制1a HCVcc基因型.
- N2免疫增加了IFN-γ ELISPOT数量和CD8+ T细胞频率 (granzyme B+/perforin+),IL-4的水平较低.
- 在实验室中,sE2-N2证明了细胞溶解的改善,在体内减缓了瘤生长,在治疗环境中减少了病毒RNA和肝脏标记物,并引起了强大的中和抗体 (1C1).
结论:
- 在E2上选择性去除N2甘氨酸可保持抗原性,并增强幽默和细胞免疫力.
- 编辑E2的N-glycan是改善HCV疫苗候选人的可行策略.
- 经N2修饰的E2抗原显示出对抗HCV的治疗应用的前景.
相关概念视频
01:29Immune Response Against Viral Pathogens
2.2K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
2.2K
01:27Cytotoxic T Cells-mediated Immune Response
7.7K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.7K